Liver Carcinoma — Trials

Liver Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

3,370 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 783
Recruiting: 463
Ph III recruiting: 41
Growth YoY: +1.5%
Industry share: 21%
Top sponsor: Sun Yat-sen University
Termination share: 34.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (387)

clinicaltrialsPublishedShowing 3,051–3,100 of 3,370 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02113865	Score System for Prediction Risk and Early Diagnosis of HCC in HIV/HCV Patients	completed	—	45	Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y CajalOTHER	1	Mar 9, 2015	clinicaltrials
NCT01203787	Sorafenib Dose Ramp-Up in Hepatocellular Carcinoma (HCC)	completed	Phase 4	120	University of FloridaOTHER	1	Mar 5, 2015	clinicaltrials